Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Experimental and Regenerative Neurosciences, School of Biological Sciences, University of Western Australia, Perth, Western Australia, Australia.
Glia. 2019 Aug;67(8):1462-1477. doi: 10.1002/glia.23620. Epub 2019 Apr 16.
Neuronal activity is a potent extrinsic regulator of oligodendrocyte generation and central nervous system myelination. Clinically, repetitive transcranial magnetic stimulation (rTMS) is delivered to noninvasively modulate neuronal activity; however, the ability of rTMS to facilitate adaptive myelination has not been explored. By performing cre-lox lineage tracing, to follow the fate of oligodendrocyte progenitor cells in the adult mouse brain, we determined that low intensity rTMS (LI-rTMS), administered as an intermittent theta burst stimulation, but not as a continuous theta burst or 10 Hz stimulation, increased the number of newborn oligodendrocytes in the adult mouse cortex. LI-rTMS did not alter oligodendrogenesis per se, but instead increased cell survival and enhanced myelination. These data suggest that LI-rTMS can be used to noninvasively promote myelin addition to the brain, which has potential implications for the treatment of demyelinating diseases such as multiple sclerosis.
神经元活动是调节少突胶质细胞生成和中枢神经系统髓鞘形成的一种有效外在调节因子。临床上,重复经颅磁刺激(rTMS)用于非侵入性地调节神经元活动;然而,rTMS 促进适应性髓鞘形成的能力尚未得到探索。通过进行 cre-lox 谱系追踪,以追踪成年小鼠大脑中少突胶质前体细胞的命运,我们确定低强度 rTMS(LI-rTMS),作为间歇性 theta 爆发刺激给药,而不是连续 theta 爆发或 10 Hz 刺激,可增加成年小鼠大脑皮层中新生少突胶质细胞的数量。LI-rTMS 本身并不会改变少突胶质细胞的生成,而是增加了细胞的存活并增强了髓鞘形成。这些数据表明,LI-rTMS 可用于非侵入性地促进大脑髓鞘的增加,这对于治疗多发性硬化等脱髓鞘疾病具有潜在意义。